Ladan Fazli

Ladan Fazli

Vancouver, BC V6H3Z6, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 278 publications

Distinct transcription factor interactions drive HOXB13 activity in different stages of prostate cancer.

Distinct transcription factor interactions drive HOXB13 activity in different stages of prostate cancer.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: December 04, 2025

Correction: Menin inhibition suppresses castration-resistant prostate cancer and enhances chemosensitivity.

Correction: Menin inhibition suppresses castration-resistant prostate cancer and enhances chemosensitivity.

Journal: Oncogene

Published: October 29, 2025

DDX5 mRNA-targeting antisense oligonucleotide as a new promising therapeutic in combating castration-resistant prostate cancer.

DDX5 mRNA-targeting antisense oligonucleotide as a new promising therapeutic in combating castration-resistant prostate cancer.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: September 12, 2025

A dual role of EZH2 in regulating A-to-I RNA editing and mRNA stability through ADAR.

A dual role of EZH2 in regulating A-to-I RNA editing and mRNA stability through ADAR.

Journal: Nature communications

Published: August 18, 2025

Correction: Heat shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through eIF4E.

Correction: Heat shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through eIF4E.

Journal: Oncogene

Published: August 07, 2025

Noncanonical functions of UGT2B17 promote castration-resistant prostate cancer progression.

Noncanonical functions of UGT2B17 promote castration-resistant prostate cancer progression.

Journal: The Journal of clinical investigation

Published: June 10, 2025

Prognostic Significance of the Cytoplasmic Expression of UDP-glucuronosyltransferase 2B17 in Localized Prostate Cancer: Insights from the Canadian Prostate Cancer Biomarker Network and PROCURE Multi-institutional Cohorts.

Prognostic Significance of the Cytoplasmic Expression of UDP-glucuronosyltransferase 2B17 in Localized Prostate Cancer: Insights from the Canadian Prostate Cancer Biomarker Network and PROCURE Multi-institutional Cohorts.

Journal: European urology oncology

Published: May 16, 2025

Identifying Rare Germline Variants Associated with Metastatic Prostate Cancer Through an Extreme Phenotype Study.

Identifying Rare Germline Variants Associated with Metastatic Prostate Cancer Through an Extreme Phenotype Study.

Journal: medRxiv : the preprint server for health sciences

Published: May 09, 2025

Corrigendum to "RNA Splicing of the BHC80 Gene Contributes to Neuroendocrine Prostate Cancer Progression" [Eur. Urol. 76(2) (2019) 157-166].

Corrigendum to "RNA Splicing of the BHC80 Gene Contributes to Neuroendocrine Prostate Cancer Progression" [Eur. Urol. 76(2) (2019) 157-166].

Journal: European urology

Published: May 08, 2025

ERRATUM: Roles of the HOXA10 gene during castrate-resistant prostate cancer progression.

ERRATUM: Roles of the HOXA10 gene during castrate-resistant prostate cancer progression.

Journal: Endocrine-related cancer

Published: April 18, 2025

Editorial Expression of Concern: Heat shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through eIF4E.

Editorial Expression of Concern: Heat shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through eIF4E.

Journal: Oncogene

Published: April 10, 2025

The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer.

The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer.

Journal: Cell reports

Published: April 05, 2025

Showing 1-12 of 278

Last Updated: 09/26/2026